Perrigo Company plc Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less
Perrigo Company plc (PRGO) reported Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less of -$5.90 million for the 3-month period ending 2023-04-01, per its 10-Q filed 2023-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess · last filed 2023-05-09
- Perrigo Company plc proceeds from (repayments of) short-term debt, maturing in three months or less for the quarter ending 2023-04-01 was -$5.90M.
- Perrigo Company plc proceeds from (repayments of) short-term debt, maturing in three months or less for the quarter ending 2022-12-31 was -$5.80M.
- Perrigo Company plc proceeds from (repayments of) short-term debt, maturing in three months or less for the quarter ending 2022-10-01 was -$5.90M.
- Perrigo Company plc proceeds from (repayments of) short-term debt, maturing in three months or less for the quarter ending 2022-07-02 was $0.00.
- Perrigo Company plc proceeds from (repayments of) short-term debt, maturing in three months or less for fiscal 2022 was -$11.70M.
- Perrigo Company plc proceeds from (repayments of) short-term debt, maturing in three months or less for fiscal 2021 was -$30.60M.
- Perrigo Company plc proceeds from (repayments of) short-term debt, maturing in three months or less for fiscal 2020 was -$3.90M, a 880.00% decline from fiscal 2019.
- Perrigo Company plc proceeds from (repayments of) short-term debt, maturing in three months or less for fiscal 2019 was $500.00K.
| Period end | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 3 month | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 3 month as first filed | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 6 month | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 6 month as first filed | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 9 month | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 9 month as first filed | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 12 month | Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-04-01 | -$5.90M 10-Q · filed 2023-05-09 | -$11.70M derived: sum of 2 quarters · filed 2023-05-09 | -$17.60M derived: sum of 3 quarters · filed 2023-05-09 | -$17.60M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2022-12-31 | -$5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$11.70M derived: sum of 2 quarters · filed 2023-02-28 | -$11.70M derived: sum of 3 quarters · filed 2023-02-28 | -$11.70M 10-K · filed 2023-02-28 | ||||
| 2022-10-01 | -$5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$5.90M derived: sum of 2 quarters · filed 2022-11-08 | -$5.90M 10-Q · filed 2022-11-08 | -$30.70M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2022-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | -$24.80M derived: sum of 3 quarters · filed 2023-05-09 | -$24.80M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2022-04-02 | $0.00 10-Q · filed 2023-05-09 | -$24.80M derived: sum of 2 quarters · filed 2023-05-09 | -$24.80M derived: sum of 3 quarters · filed 2023-05-09 | -$30.60M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$24.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$24.80M derived: sum of 2 quarters · filed 2023-02-28 | -$30.60M derived: sum of 3 quarters · filed 2023-02-28 | -$30.60M 10-K · filed 2023-02-28 | ||||
| 2021-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$5.80M derived: sum of 2 quarters · filed 2022-11-08 | -$5.80M 10-Q · filed 2022-11-08 | -$9.80M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-07-03 | -$5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$5.80M 10-Q · filed 2022-08-09 | -$9.80M derived: sum of 3 quarters · filed 2023-02-28 | -$11.30M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-04-03 | $0.00 10-Q · filed 2021-05-12 | -$4.00M derived: sum of 2 quarters · filed 2023-02-28 | -$5.50M derived: sum of 3 quarters · filed 2023-02-28 | -$105.90M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$5.50M derived: sum of 2 quarters · filed 2023-02-28 | -$105.90M derived: sum of 3 quarters · filed 2023-02-28 | -$3.90M 10-K · filed 2023-02-28 | ||||
| 2020-09-26 | -$1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$101.90M derived: sum of 2 quarters · filed 2021-11-12 | $100.00K 10-Q · filed 2021-11-12 | -$200.00K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-27 | -$100.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $1.60M 10-Q · filed 2021-08-11 | $1.30M derived: sum of 3 quarters · filed 2022-03-01 | -$395.40M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-28 | $102.00M 10-Q · filed 2021-05-12 | $101.70M derived: sum of 2 quarters · filed 2022-03-01 | -$295.00M derived: sum of 3 quarters · filed 2022-03-01 | $102.80M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$397.00M derived: sum of 2 quarters · filed 2022-03-01 | $800.00K derived: sum of 3 quarters · filed 2022-03-01 | $500.00K 10-K · filed 2022-03-01 | ||||
| 2019-09-28 | -$396.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.10M derived: sum of 2 quarters · filed 2020-11-05 | $800.00K 10-Q · filed 2020-11-05 | $5.10M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-29 | $397.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $397.50M 10-Q · filed 2020-08-05 | $401.80M derived: sum of 3 quarters · filed 2021-03-01 | $401.30M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-30 | -$300.00K 10-Q · filed 2020-05-05 | $4.00M derived: sum of 2 quarters · filed 2021-03-01 | $3.50M derived: sum of 3 quarters · filed 2021-03-01 | $1.50M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $3.80M derived: sum of 2 quarters · filed 2021-03-01 | $1.80M derived: sum of 3 quarters · filed 2021-03-01 | -$4.40M 10-K · filed 2021-03-01 | ||||
| 2018-09-29 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$2.50M derived: sum of 2 quarters · filed 2019-11-06 | -$8.70M 10-Q · filed 2019-11-06 | -$1.90M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$8.20M 10-Q · filed 2019-08-08 | -$1.40M derived: sum of 3 quarters · filed 2020-02-27 | -$1.40M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$6.20M 10-Q · filed 2019-05-09 | $600.00K derived: sum of 2 quarters · filed 2020-02-27 | $600.00K derived: sum of 3 quarters · filed 2020-02-27 | $300.00K derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $6.80M derived: sum of 2 quarters · filed 2020-02-27 | $6.50M derived: sum of 3 quarters · filed 2020-02-27 | $6.80M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$300.00K derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | $1.10M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-07-01 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | $1.10M derived: sum of 3 quarters · filed 2019-02-27 | $1.40M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-04-01 | $300.00K 10-Q · filed 2018-05-08 | $1.40M derived: sum of 2 quarters · filed 2019-02-27 | $1.70M derived: sum of 3 quarters · filed 2019-02-27 | -$86.30M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $1.40M derived: sum of 2 quarters · filed 2019-02-27 | -$86.60M derived: sum of 3 quarters · filed 2019-02-27 | -$802.50M 10-K · filed 2019-02-27 | ||||
| 2016-10-01 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$87.70M derived: sum of 2 quarters · filed 2017-11-09 | -$803.60M 10-Q · filed 2017-11-09 | -$164.60M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-07-02 | -$88.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$803.90M 10-Q · filed 2017-08-10 | -$164.90M derived: sum of 3 quarters · filed 2018-03-01 | -$85.90M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-04-02 | -$715.90M 10-Q · filed 2017-05-30 | -$704.30M 10-Q · filed 2016-05-16 | -$76.90M derived: sum of 2 quarters · filed 2018-03-01 | $2.10M derived: sum of 3 quarters · filed 2018-03-01 | -$53.30M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $639.00M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01 | $718.00M 10-K · filed 2018-03-01 | $762.00M 10-KT · filed 2016-02-25 | $662.60M derived: sum of 3 quarters · filed 2018-03-01 | $666.00M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-09-26 | $79.00M 10-Q · filed 2015-11-02 | $23.60M derived: sum of 2 quarters · filed 2017-05-22 | $27.60M 10-Q/A · filed 2017-05-23 | $28.60M 10-Q · filed 2016-11-10 | ||||
| 2015-06-27 | -$55.40M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | -$52.00M 10-Q/A · filed 2017-05-22 | -$50.40M 10-Q · filed 2016-08-10 | -$54.00M 10-K · filed 2018-03-01 | -$52.50M 10-K · filed 2015-08-13 | |||
| 2015-03-28 | $3.40M 10-Q/A · filed 2017-05-22 | |||||||
| 2014-09-27 | -$2.10M 10-Q · filed 2015-11-02 | |||||||
| 2014-06-28 | -$3.00M 10-K · filed 2017-05-22 | |||||||
| 2013-06-29 | $5.00M 10-KT · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |